Search peptides, terms, sources/
Research source · 2018

Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder

About this source

Kind
Research
Design
Human clinical trial
Population
Autism spectrum disorder, long-term intranasal oxytocin users, pooled across included trials
Primary or secondary
secondary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Long-term/repeated-dose safety data specifically is described in the broader literature as sparser than acute-dose safety data.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.